AQR Capital Management’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-57,106
Closed -$66.8K 2855
2024
Q2
$66.8K Buy
+57,106
New +$66.8K ﹤0.01% 2526